Sports / Entertainment

PolyMedix Promotes Bozena Korczak to Senior Vice President, Drug Development and Chief Development Officer
PolyMedix, Inc. , an emerging biotechnology company focused on developing new therapeutic drugs for the treatment of serious infectious diseases and acute cardiovascular disorders, announces the promotion of Bozena Korczak, Ph.D. to Senior Vice President, Drug Development and Chief Development Officer.

Read more on Business Wire via Yahoo! Finance

Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer
– Executive with 25 years of biotech and pharmaceutical experience to lead company preparing to sub…

Read more on citybizlist Philadelphia

NKT Therapeutics Announces Hiring of Barbara Finck, M.D. as Chief Medical Officer
NKT Therapeutics, Inc., a privately held biotechnology company, today announced the appointment of Barbara Finck, M.D. to the position of Chief Medical Officer.

Read more on Business Wire via Yahoo! Finance

Creabilis Appoints Dr. Eliot Forster as its New Chief Executive Officer
LUXEMBOURG , September 29, 2010 /PRNewswire/ — Creabilis SA, a clinical stage European biotechnology company addressing significant unmet medical needs in dermatological diseases, today announced the appointment of Eliot Forster as its new Chief Executive Officer. Dr Forster brings to Creabilis significant drug development experience having brought a number of molecules to market. Dr Forster …

Read more on redOrbit

Calistoga Pharmaceuticals Appoints Andrew Guggenhime as Chief Financial Officer
SEATTLE–(BUSINESS WIRE)–Calistoga Pharmaceuticals appoints Andrew Guggenhime Chief Financial Officer. Guggenhime previously served as CFO for public biotechnology companies including Facet Biotech and PDL BioPharma, Inc.

Read more on Business Wire

CytoGenix, Inc. Announces the Appointment of a New Chief Financial Officer
NEW BRAUNFELS, Texas—-CytoGenix, Inc. today announced the resignation of Mr. Randy Moseley, Chief Financial Officer and Chairman of the Board from all positions within CytoGenix and the appointment of Steven M.

Read more on Business Wire via Yahoo! Finance

Tengion Appoints A. Brian Davis Chief Financial Officer
Tengion Inc. today announced that it has appointed A. Brian Davis to the position of Chief Financial Officer. Â Mr. Davis comes to Tengion after 15 years with Neose Technologies, Inc., a biopharmaceutical company using enzymatic technologies to develop improved protein therapeutics.

Read more on PR Newswire via Yahoo! Finance

AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer
BURLINGTON, Mass.—-AlloCure Inc., a biotechnology company pioneering the use of cell therapies for the treatment of kidney diseases, today announced the appointment of Robert M. Brenner, M.D., as President and Chief Executive Officer.

Read more on Business Wire via Yahoo! Finance

Ablexis Appoints R. Scott Greer Chairman of the Board and Richard Hoffman Chief Business Officer
SAN FRANCISCO—-Ablexis, LLC, a biotechnology company dedicated to developing the AlivaMab Mouse, an innovative next-generation platform for antibody drug discovery, announced today the appointments of R.

Read more on Business Wire via Yahoo! Finance

RAGLAN T-SHIRT WHITE AND BLACK ” USA BIOTECHNOLOGY TECHNICAL OFFICER ” Large